Description
The Defense Health Agency (DHA) intends to issue a sole source contract award to Vista LifeSciences, LLC for Automated Neuropsychological Assessment Metrics (ANAM) Software. The software is a proprietary, computer-based, FDA-cleared cognitive assessment tool designed to detect and measure the speed and accuracy of attention, memory, and thinking ability. The base period of performance will begin on 30 Jul 2026 for six months, with one six-month option period.
Key features of the ANAM software include:
• Over 30 cognitive tests
• Mood questionnaires
• Reporting metrics
• Clinical and military-grade neurocognitive testing suite
• Vital for pre-deployment baseline testing and clinical health system management
All interested sources may submit an authorized letter from the manufacturer with detailed information and convincing evidence that clearly demonstrates the authority to provide ANAM Software for the requirement as outlined above.
Attached files
Contact
Joseph Preusser(Contracting Officer)